Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P02794 (
ferritin
)
17,525
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A year-long double-blind study of 2,3-dihydroxybenzoic acid (2,3-
DHB
) given orally at a dose of 25 mg/kg four times per day was undertaken in 15 patients with beta-thalassemia major. 2,3-
DHB
and placebo (mannitol) were tolerated to an equal degree and there were no signs of drug toxicity at the end of 1 year. Efficacy in terms of retardation of iron accumulation could be documented using serial liver biopsies, serum
ferritin
determinations, or clinical laboratory assessment. Serum iron values increased, as did the iron binding capacity, in the group receiving 2,3-
DHB
. The increase in iron binding capacity was due to drug interference with the method of determination. Because of the greater efficacy of slow infusions of desferrioxamine in chelating iron when administered slowly, the clinic has shifted its emphasis toward further evaluation of that compound. Nevertheless, in view of the minimal toxicity of 2,3-
DHB
, further work appears warranted to define its role in the treatment of iron-overload.
...
PMID:Chelation therapy in beta-thalassemia major: a one-year double blind study of 2,3-dihydroxybenzoic acid. 37 74
1. The effect of iron chelators on iron uptake,
ferritin
and total protein synthesis was studied in cultured Chang cells. Desferrioxamine depressed
ferritin
synthesis and completely inhibited iron uptake by
ferritin
protein. Rhodotorulic acid reduced iron uptake by the cells but had little effect on
ferritin
synthesis. Diethylenetriamine pentaacetic acid produced complete inhibition of iron uptake and all protein synthesis. 2,3-Dihydroxybenzoic acid (2,3-
DHB
) had no effect in this system. 2. When 2,3-
DHB
was incubated with a liver homogenate, its subsequent addition to a Chang cell culture resulted in depression of
ferritin
synthesis, iron uptake into the protein and some depression of total protein synthesis. Pretreatment of rhodotorulic acid did not affect its properties. 3. Non-
ferritin
iron in the Chang cell cytosol was dialysable, available for binding to transferrin and formed chelates which appeared, on gel chromatography, to be of low molecular weight. Gel chromatography of cytosol after incubation of the cells with chelating agents showed non-
ferritin
iron to be in a similar form. 4. Loss of non-
ferritin
iron from the cells occurred only when the transferrin in the medium was unsaturated. In the presence of chelating agents non-
ferritin
iron was lost from the cells even when transferrin was 100% saturated. 5. The results confirm the presence of an intracellular labile iron pool which is available for chelation, and demonstration that different iron chelators have different metabolic effects.
...
PMID:The effect of chelating agents on cellular iron metabolism. 125 27